144 related articles for article (PubMed ID: 24599129)
1. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma.
Favaro R; Appolloni I; Pellegatta S; Sanga AB; Pagella P; Gambini E; Pisati F; Ottolenghi S; Foti M; Finocchiaro G; Malatesta P; Nicolis SK
Cancer Res; 2014 Mar; 74(6):1833-44. PubMed ID: 24599129
[TBL] [Abstract][Full Text] [Related]
2. Sox2-dependent maintenance of mouse oligodendroglioma involves the Sox2-mediated downregulation of Cdkn2b, Ebf1, Zfp423, and Hey2.
Barone C; Buccarelli M; Alessandrini F; Pagin M; Rigoldi L; Sambruni I; Favaro R; Ottolenghi S; Pallini R; Ricci-Vitiani L; Malatesta P; Nicolis SK
Glia; 2021 Mar; 69(3):579-593. PubMed ID: 32975900
[TBL] [Abstract][Full Text] [Related]
3. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
4. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
[TBL] [Abstract][Full Text] [Related]
5. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of malignancy in a mouse model for oligodendroglioma.
Weiss WA; Burns MJ; Hackett C; Aldape K; Hill JR; Kuriyama H; Kuriyama N; Milshteyn N; Roberts T; Wendland MF; DePinho R; Israel MA
Cancer Res; 2003 Apr; 63(7):1589-95. PubMed ID: 12670909
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
8. Antitumor DNA vaccination against the Sox2 transcription factor.
Polakova I; Duskova M; Smahel M
Int J Oncol; 2014 Jul; 45(1):139-46. PubMed ID: 24789529
[TBL] [Abstract][Full Text] [Related]
9. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
Phi JH; Park SH; Kim SK; Paek SH; Kim JH; Lee YJ; Cho BK; Park CK; Lee DH; Wang KC
Am J Surg Pathol; 2008 Jan; 32(1):103-12. PubMed ID: 18162777
[TBL] [Abstract][Full Text] [Related]
10. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
[TBL] [Abstract][Full Text] [Related]
11. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.
Hütz K; Mejías-Luque R; Farsakova K; Ogris M; Krebs S; Anton M; Vieth M; Schüller U; Schneider MR; Blum H; Wagner E; Jung A; Gerhard M
Carcinogenesis; 2014 Apr; 35(4):942-50. PubMed ID: 24325912
[TBL] [Abstract][Full Text] [Related]
12. Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression.
Feng R; Zhou S; Liu Y; Song D; Luan Z; Dai X; Li Y; Tang N; Wen J; Li L
Biochem J; 2013 Mar; 450(3):459-68. PubMed ID: 23301561
[TBL] [Abstract][Full Text] [Related]
13. Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased Sox2 expression.
Liu T; Cheng W; Huang Y; Huang Q; Jiang L; Guo L
Exp Cell Res; 2012 Feb; 318(4):424-34. PubMed ID: 22200372
[TBL] [Abstract][Full Text] [Related]
14. SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.
Chen S; Li X; Lu D; Xu Y; Mou W; Wang L; Chen Y; Liu Y; Li X; Li LY; Liu L; Stupack D; Reisfeld RA; Xiang R; Li N
Carcinogenesis; 2014 Mar; 35(3):613-23. PubMed ID: 24233838
[TBL] [Abstract][Full Text] [Related]
15. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
16. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
Ge Y; Zhou F; Chen H; Cui C; Liu D; Li Q; Yang Z; Wu G; Sun S; Gu J; Wei Y; Jiang J
Biochem Biophys Res Commun; 2010 Jul; 397(4):711-7. PubMed ID: 20537983
[TBL] [Abstract][Full Text] [Related]
17. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult.
Ellis P; Fagan BM; Magness ST; Hutton S; Taranova O; Hayashi S; McMahon A; Rao M; Pevny L
Dev Neurosci; 2004; 26(2-4):148-65. PubMed ID: 15711057
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.
Sun H; Zhang S
Biochem Biophys Res Commun; 2011 Jul; 410(3):692-7. PubMed ID: 21703238
[TBL] [Abstract][Full Text] [Related]
19. Expression of Sox2 in human cervical carcinogenesis.
Ji J; Zheng PS
Hum Pathol; 2010 Oct; 41(10):1438-47. PubMed ID: 20709360
[TBL] [Abstract][Full Text] [Related]
20. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
